← Blog
Game 2

Fluxo W7M Silences FURIA to Sweep CBLOL Series

Fluxo W7M completes a dominant 2-0 sweep against FURIA in CBLOL 2026, defying draft predictions through overwhelming mid-lane and jungle pressure.

Fluxo W7MFluxo W7mWinner
Game 230:08CBLOLPatch 26.08
FURIAFuria
16Kills12
61.5KGold56.0K
5Drag0
8Torres2
Polymarket

El mercado favorecía a Fluxo W7M con 50% y ganó como se esperaba

Fluxo W7m 50.0%·Furia 50.0%·Vol: $317K

Top players by damage

Viktor
MidTutsz
3/3/546.1% dmg
Yone
Midcody
4/3/531.3% dmg
Rumble
Topcurty
4/2/731.0% dmg

The Siege of the Rift

The stakes could not have been higher for FURIA. Entering Game 2 of this CBLOL 2026 clash, they were staring down the barrel of a series defeat, needing a victory to stay alive in the tournament. The narrative heading into the match suggested a massive advantage for the red side; the pre-match models had even tipped the scales in their favor with a 60% win probability. The plan was simple: use the poke and lane dominance of their draft to crush the opposition before they could scale. However, what we witnessed was not a comeback, but a clinical execution that left the fans in stunned silence as Fluxo W7M closed the door on the series.

A Shattered Blueprint

While the draft advantage for FURIA was supposed to materialize through the lane pressure of Corki and Nami, the early game told a much different story. Instead of the suffocating presence they promised, the red side found themselves drowning in a gold deficit. The mid-lane, which was expected to be a pillar of stability, became a disaster zone. The Fluxo W7M mid-laner, playing a hyper-aggressive Yone, absolutely dismantled the opposition, carving out a massive +2,386 gold advantage at the fifteen-minute mark. This massive gap effectively neutralized the scaling potential of the enemy Viktor, who struggled to find any footing as the game progressed.

The jungle was equally chaotic. The Fluxo W7M Wukong played with a level of predatory precision, securing a +675 gold lead over the opposing Xin Zhao by the mid-game. This pressure allowed the blue side to dictate the tempo of every skirmish. Even though the top lane saw some resistance, with the enemy K'Sante managing a respectable +382 gold lead at fifteen minutes, it was simply not enough to offset the catastrophic losses occurring in the center of the map.

The Turning Point

The momentum shifted irrevocably when the objectives began to pile up for the blue side. While FURIA struggled to secure even a single dragon, Fluxo W2M was methodically stripping away their hopes, securing 5 dragons and a crucial Baron Nashor. The structural integrity of the FURIA base began to crumble under the weight of 5 towers taken by the surging blue side. The sheer gold disparity became impossible to ignore, as Fluxo W7M amassed a total of 58.7k gold compared to the meager 52.8k held by their opponents. Every time FURIA attempted to contest a fight, they were met with a wall of utility and burst that they simply could not outplay.

The Final Blow

As the clock ticked toward the thirty-minute mark, the end was inevitable. The synergy between the Jhin and Karma duo proved to be the ultimate counter to the FURIA poke strategy. The support player, playing a legendary Karma, delivered a masterclass in protection and engagement, finishing the game with a staggering 11.00 KDA and a massive 10 assists. This level of play ensured that the enemy bot lane could never find an opening to carry. By the time the nexus exploded at 29:50, the scoreboard reflected a total mismatch: 14 kills for Fluxo W7M to just 9 for FURIA.

A New Era in CBLOL

Against all odds and despite the statistical predictions, Fluxu W7M has proven that raw lane dominance and jungle control can override even the most well-constructed drafts. They didn't just win a game; they completed a 2-0 sweep that signals a massive shift in the power dynamics of the 2026 season. For FURIA, the loss is a bitter pill to swallow, leaving them to reflect on how a predicted 60% advantage evaporated into a series-ending defeat. For Fluxo W7M, the path forward looks incredibly bright as they ride the momentum of this clinical performance.